The facility will be constructed over the next two years, according to Julien Camisani, director of global equipment of cell & gene therapy. The construction will be handled by Nemaco, a Dutch-Swiss based developer noted for its construction of custom buildings for multinational corporations. Source: Genetic Engineering News 28/1/2020